Diseases · Entity Annotation Prototype (beta)

3articles mentioning diseases

3disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: triple-negative breast cancers ×

triple-negative breast cancers

This disease is selected. Its supporting articles are shown below.

triple-negative breast cancers3

Articles mentioning triple-negative breast cancers

3 articles · page 1 of 1

173 Androgen receptor stratifies immune-cold triple negative breast cancer: meta-analysis of chemotherapy response to guide precision immunotherapy

jitc · abstract · 2025-11-04 · 1 matching annotations

78.5%

TNBC triple-negative breast cancers androgen receptor antagonists neoadjuvant chemotherapy ClinicalTrials.gov EMBASE MEDLINE

…clusions AR positivity identifies a chemoresistant, immune-cold TNBC subtype with substantially lower pathologic complete response t…

360 Understanding the mechanisms of tumor immune evasion from Vδ1+ γδ T cell-mediated killing using genome-wide CRISPR-Cas9 loss-of-function screens

jitc · abstract · 2025-11-04 · 1 matching annotations

82.0%

triple-negative breast cancer triple-negative breast cancers acute myeloid leukemia Australian Red Cross

…compartment in the human breast is associated with remission in triple-negative breast cancer. Science Translational Medicine 2019;11:eaax9364.Wu Y, et al. A…

846 Flt3 ligand and CD40 agonist immunotherapy activates mature dendritic cells enriched in regulatory features with opposing IL-12 and CCL22 programs in breast cancer

jitc · abstract · 2025-11-04 · 1 matching annotations

96.7%

triple-negative breast cancers triple-negative breast tumors Doxil Flt3L

…gen presentation is a critical barrier to effective immunity in triple-negative breast cancers. We devised a triplet regimen that combines pegylated liposomal…

Browse diseases

triple-negative breast cancers

Articles mentioning triple-negative breast cancers

173 Androgen receptor stratifies immune-cold triple negative breast cancer: meta-analysis of chemotherapy response to guide precision immunotherapy

360 Understanding the mechanisms of tumor immune evasion from Vδ1+ γδ T cell-mediated killing using genome-wide CRISPR-Cas9 loss-of-function screens

846 Flt3 ligand and CD40 agonist immunotherapy activates mature dendritic cells enriched in regulatory features with opposing IL-12 and CCL22 programs in breast cancer